Radboud University Nijmegen Medical Centre / Radboudumc of voluit Radboud Universitair Medisch Centrum (UMC)
Hospital
Location:
Nijmegen,
Netherlands (NL)
ISNI: 0000000404449382
ROR: https://ror.org/05wg1m734
Neurological and psychiatric adverse effects of long-term methylphenidate treatment in ADHD: A map of the current evidence (2019)
Krinzinger H, Hall CL, Groom MJ, Ansari MT, Banaschewski T, Buitelaar JK, Carucci S, et al.
Journal article, Review article
GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways (2019)
López-Isac E, Acosta-Herrera M, Kerick M, Assassi S, Satpathy AT, Granja J, Mumbach MR, et al.
Journal article
Bi-allelic Variants in METTL5 Cause Autosomal-Recessive Intellectual Disability and Microcephaly (2019)
Richard EM, Polla DL, Assir MZ, Contreras M, Shahzad M, Khan AA, Razzaq A, et al.
Journal article
Delineating the clinical spectrum due to heterozygous TRAF7 missense mutations: A series of 38 cases (2019)
Amiel J, Mishra K, Castilla L, Selmer KK, Barak T, Yang S, Blanco-Sanchez B, et al.
Conference contribution
Delineation of the clinical phenotype caused by de novo CLTC variants (2019)
Sa MJN, Venselaar H, Wiel L, Trimouille A, Lasseaux E, Naudion S, Lacombe D, et al.
Conference contribution
Impact of Eligibility Criteria on Clinical Outcomes of Firehawk and XIENCE Coronary Drug-Eluting Stent in an All-Comers Randomized Trial (2019)
Saito Y, Wijns W, Baumbach A, Xu B, Kelbaek H, Van Royen N, Zheng M, et al.
Conference contribution
Physiotherapy improves motor function in patients with the Parkinson variant of multiple system atrophy: A prospective trial (2019)
Raccagni C, Goebel G, Gaßner H, Granata R, Ndayisaba JP, Seebacher B, Schoenherr G, et al.
Journal article
Biomarker results from a phase II study of MEK1/2 inhibitor binimetinib (MEK162) in patients with advanced NRAS- or BRAF-mutated melanoma (2019)
Van Herpen CM, Agarwala SS, Hauschild A, Berking C, Thaddeus Beck J, Schadendorf D, Jansen R, et al.
Journal article
Cost-effectiveness of SelectMDx for prostate cancer in four European countries: a comparative modeling study (2019)
Govers TM, Hessels D, Vlaeminck-Guillem V, Schmitz-Draeger BJ, Stief CG, Martinez-Ballesteros C, Ferro M, et al.
Journal article
Three years of obeticholic Acid (OCA) therapy results in histological improvements in patients with primary biliary cholangitis: further analysis of the POISE Biopsy substudy (2019)
Bowlus CL, Pockros PJ, Kremer A, Pares A, Forman LM, Drenth JPH, Ryder S, et al.
Conference contribution